The cellular neurobiology of depression

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nature Medicine

• Publication date

  2001-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/87865PMID 11329053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders.

  2001cited by this paper
• Control of synapse number by glia.

  2001cited by this paper
• The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory

  2001cited by this paper
• Regulation of hippocampal neurogenesis in adulthood.

  2000cited by this paper
• Signaling: cellular insights into the pathophysiology of bipolar disorder.

  2000cited by this paper
• Neuroimaging studies of mood disorders.

  2000cited by this paper
• Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells.

  2000cited by this paper
• Neuronal plasticity and survival in mood disorders.

  2000cited by this paper
• Adult brain neurogenesis and psychiatry: a novel theory of depression

  2000cited by this paper
• Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

  2000cited by this paper
• Neuroplasticity and cellular resilience in mood disorders

  2000cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

  2000cited by this paper
• Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders.

  2000cited by this paper
• The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review.

  2000cited by this paper
• Enhancement of Hippocampal Neurogenesis by Lithium

  2000cited by this paper
• The Corticosteroid Receptor Hypothesis of Depression

  2000cited by this paper
• Association between depression and mortality in older adults: the Cardiovascular Health Study.

  2000cited by this paper
• Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.

  2000cited by this paper
• CREB couples neurotrophin signals to survival messages.

  2000cited by this paper
• Mind glue: implications of glial cell biology for psychiatry.

  2000cited by this paper
• Designing small-molecule switches for protein-protein interactions.

  2000cited by this paper
• Lithium-induced increase in human brain grey matter.

  2000cited by this paper
• Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus

  2000cited by this paper
• Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles.

  1999cited by this paper
• The effects of neonatal stress on brain development: Implications for psychopathology

  1999cited by this paper
• Emergent properties of networks of biological signaling pathways.

  1999cited by this paper
• The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders.

  1999cited by this paper
• Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease.

  1999cited by this paper
• Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

  1999cited by this paper
• Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

  1999cited by this paper
• Nongenomic transmission across generations of maternal behavior and stress responses in the rat.

  1999cited by this paper
• Neurogenesis in the neocortex of adult primates.

  1999cited by this paper
• Functional Micro-Organization of Primary Visual Cortex: Receptive Field Analysis of Nearby Neurons

  1999cited by this paper
• Stress and hippocampal plasticity.

  1999cited by this paper
• Trophic regulation of synaptic plasticity.

  1999cited by this paper
• Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

  1999cited by this paper
• Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons.

  1999cited by this paper
• Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression

  1999cited by this paper
• Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.

  1999cited by this paper
• Hippocampal Remodeling and Damage by Corticosteroids: Implications for Mood Disorders

  1999cited by this paper
• Treatment of depression with antiglucocorticoid drugs.

  1999cited by this paper
• Corticotropin-releasing factor antagonists in affective disorders.

  1999cited by this paper
• The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS

  1999cited by this paper
• Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy

  1999cited by this paper
• Glial reduction in the subgenual prefrontal cortex in mood disorders.

  1998cited by this paper
• The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment.

  1998cited by this paper
• Neurogenesis in the adult human hippocampus

  1998cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• Antidepressant treatments in the 21st century.

  1998cited by this paper
• Psychosomatic Aspects of Cushing’s Disease

  1998cited by this paper
• Monoamine dysfunction and the pathophysiology and treatment of depression.

  1998cited by this paper
• Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients.

  1998cited by this paper
• The effects of stressful life events on depression.

  1997cited by this paper
• Bcl-2 promotes regeneration of severed axons in mammalian CNS

  1997cited by this paper
• Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.

  1997cited by this paper
• A molecular and cellular theory of depression.

  1997cited by this paper
• Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo.

  1996cited by this paper
• A molecular mechanism for the effect of lithium on development.

  1996cited by this paper
• Bone mineral density in women with depression.

  1996cited by this paper
• Psychopharmacology: The Fourth Generation of Progress.

  1996cited by this paper
• Mood Disorders in Neurodegenerative Diseases.

  1996cited by this paper
• Mood Disorders in Neurodegenerative Diseases.

  1996cited by this paper
• Psychopharmacology: The Fourth Generation of Progress

  1995cited by this paper
• N-acetylaspartate in neuropsychiatric disorders.

  1995cited by this paper
• The role of acetylcholine mechanisms in mood disorders

  1995cited by this paper
• Molecular machines integrate coincident synaptic signals.

  1993cited by this paper
• Neurotransmitters and neuromodulators in the basal ganglia.

  1990cited by this paper
• Affective Disorders and Cerebral Vascular Disease

  1989cited by this paper

• New co-drugs of O-demethylvenlafaxine and NSAIDs exert antidepressant effects by alleviating inflammation, oxidative stress, and increasing neurotransmitter.

  2026cites this paper
• ZEBRAFISH AS A COMPREHENSIVE ALTERNATIVE MODEL OF DEPRESSION BEHAVIORAL DISORDERS

  2026cites this paper
• Tryptophan depletion, serotonin, and depression: where do we stand?

  2025cites this paper
• Gut–Brain Axis in Mood Disorders: A Narrative Review of Neurobiological Insights and Probiotic Interventions

  2025cites this paper
• Nitrous oxide activates layer 5 prefrontal neurons via SK2 channel inhibition for antidepressant effect

  2025cites this paper
• Depression in mice causes decreased neuronal excitability and enhanced frequency adaptation in medial prefrontal cortex pyramidal neurons

  2025cites this paper
• High-frequency transcranial magnetic stimulation decreases dorsal striatum dopamine D2 receptors in a rat model of depression.

  2025cites this paper
• Gut Microbiome, Diet and Depression: Literature Review of Microbiological, Nutritional and Neuroscientific Aspects

  2025cites this paper
• Cannabigerol and Cannabinoid Receptors in Major Depressive Disorder: Network Pharmacology, Molecular Docking, and In-vivo Analysis.

  2025cites this paper
• Role of Dehydroepiandrosterone (DHEA) in the Pathophysiology and Clinical Manifestations of Polycystic Ovary Syndrome (PCOS)

  2025cites this paper
• Rumex acetosa L. enhance learning and cognitive function by modulating NMDA receptor and BDNF pathways in vitro and in vivo

  2025cites this paper
• RGS4 Actions in Mouse Prefrontal Cortex Modulate Behavioral and Transcriptomic Responses to Chronic Stress and Ketamine

  2024cites this paper
• Nitrous Oxide activates layer 5 prefrontal neurons via SK2 channel inhibition for antidepressant effect

  2024cites this paper
• Hypocretin‐1/Hypocretin Receptor 1 Regulates Neuroplasticity and Cognitive Function through Hippocampal Lactate Homeostasis in Depressed Model

  2024cites this paper
• Role of Glial Cells in Neuronal Function, Mood Disorders, and Drug Addiction

  2024cites this paper
• Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis.

  2024cites this paper
• Analysis of medication rule of Traditional Chinese Medicine in treating depression based on data mining

  2024cites this paper
• Effects of Ellagic Acid Supplementation on Antioxidant Status and Symptom Improvement in Patients with Major Depressive Disorder: A Double-blind Randomized Clinical Trial

  2024cites this paper
• Serum Metabolomics Analysis Revealed Metabolic Pathways Related to AECOPD Complicated with Anxiety and Depression

  2024cites this paper
• Deciphering the role of miRNA-134 in the pathophysiology of depression: A comprehensive review

  2024cites this paper
• Hematological features of mine-blast trauma, accompanied by acubarotrauma, among servicemen - participants in high-intensity combat operations

  2024cites this paper
• Chronic social defeat stress induces the down‐regulation of the Nedd4L‐GLT‐1 ubiquitination pathway in the prefrontal cortex of mice

  2024cites this paper
• Anatomy and connectivity of the Göttingen minipig subgenual cortex (Brodmann area 25 homologue)

  2024cites this paper
• Beyond the blur: Scopolamine's utility and limits in modeling cognitive disorders across sexes - narrative review.

  2024cites this paper
• (-)-Syringaresinol Exerts an Antidepressant-like Activity in Mice by Noncompetitive Inhibition of the Serotonin Transporter

  2024cites this paper
• Honey on brain health: A promising brain booster

  2023cites this paper
• Recent Studies on the Development of Nicotine Abuse and Behavioral Changes Induced by Chronic Stress Depending on Gender

  2023cites this paper
• Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature

  2023cites this paper
• The medial prefrontal cortex and the cardiac baroreflex activity: physiological and pathological implications

  2023cites this paper
• Estrogen fluctuations during the menopausal transition are a risk factor for depressive disorders

  2023cites this paper
• Effects of electroconvulsive therapy on cerebral A1 adenosine receptor availability: a PET study in patients suffering from treatment-resistant major depressive disorder

  2023cites this paper
• A Study of Brain Function Characteristics of Service Members at High Risk for Accidents in the Military

  2023cites this paper
• Etomidate Improves the Antidepressant Effect of Electroconvulsive Therapy by Suppressing Hippocampal Neuronal Ferroptosis via Upregulating BDNF/Nrf2

  2023cites this paper
• Behavioral, Biochemical and Histopathological Evaluation of Sinapic acid for Antidepressant activity in Normal Mice and Stressed Mice

  2023cites this paper
• Brain damage from recurrent relapses of bipolar mania: A call for early LAI use

  2023cites this paper
• Input-output relation of midbrain connectomics in a rodent model of depression.

  2023cites this paper
• Reviewing the neurobiology of electroconvulsive therapy on a micro- meso- and macro-level.

  2023cites this paper
• Pharmacokinetics of Nasal Esketamine in Patients with Allergic Rhinitis with and Without Nasal Decongestant Pretreatment and in Healthy Subjects with and Without Nasal Corticosteroid Pretreatment

  2023cites this paper
• Intestinal activating transcription factor 4 regulates stress-related behavioral alterations via paraventricular thalamus in male mice

  2023cites this paper
• Neuropharmacological and antiproliferative activity of Tetrastigma leucostaphyllum (Dennst.) Alston: Evidence from in-vivo, in-vitro and in-silico approaches

  2023cites this paper
• Production and perspective approach of ellagic acid from mango pulp industrial waste by the Micrococcus luteus

  2023cites this paper
• Downregulation of cyclic adenosine monophosphate levels in leukocytes of hibernating captive black bears is similar to reported cyclic adenosine monophosphate findings in major depressive disorder

  2023cites this paper
• Connecting Dots between Mitochondrial Dysfunction and Depression

  2023cites this paper
• The preconditioning effect of different exercise training modes on middle cerebral artery occlusion induced-behavioral deficit in senescent rats

  2023cites this paper
• Pretreatment with lovastatin improves depression-like behavior after traumatic brain injury through activation of the AMPK pathway.

  2023cites this paper
• Potential Antioxidant Activity of Apigenin in the Obviating Stress-Mediated Depressive Symptoms of Experimental Mice

  2022cites this paper
• Long noncoding RNA Gm2694 drives depressive-like behaviors in male mice by interacting with GRP78 to disrupt endoplasmic reticulum homeostasis

  2022cites this paper
• Psychological stress induces depressive-like behavior associated with bone marrow-derived monocyte infiltration into the hippocampus independent of blood–brain barrier disruption

  2022cites this paper
• Indole Acetic Acid Exerts Anti-Depressive Effects on an Animal Model of Chronic Mild Stress

  2022cites this paper
• Mental and Physical Health Pathways Linking Insomnia Symptoms to Cognitive Performance 14 Years Later.

  2022cites this paper
• Clinical research diagnostic criteria for bipolar illness (CRDC-BP): rationale and validity

  2022cites this paper
• Antidepressant Effect of Crocin in Mice with Chronic Mild Stress

  2022cites this paper
• The role of mGlu2/3 receptor antagonists in the enhancement of the antidepressant-like effect of ketamine.

  2022cites this paper
• Suicidal Behavior and Its Relationship with Postmortem Forensic Toxicological Findings

  2022cites this paper
• A Herbal Mixture of Sesami Semen Nigrum and Longan Arillus Induces Neurite Outgrowth in Cultured Neurons and Shows Anti-Depression in Chronic Mild Stress-Induced Rats

  2022cites this paper
• Persistent Ventral Anterior Cingulate Cortex and Resolved Amygdala Hyper-responses to Negative Outcomes After Depression Remission: A Combined Cross-sectional and Longitudinal Study.

  2022cites this paper
• An insight through various models being used for Assessment of depression and its management at primary level in current scenario.

  2022cites this paper
• Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update

  2022cites this paper
• Neurobiology of Depression: Chronic Stress Alters the Glutamatergic System in the Brain—Focusing on AMPA Receptor

  2022cites this paper
• Deficiency of astrocyte CysLT1R ameliorates depression-like behaviors in mice by modulating glutamate synaptic transmission.

  2022cites this paper
• Effect of Low-Dose Statins in Addition to Standard Therapy on Brain Perfusion and Neurocognitive Performance in Patients with Major Depressive Disorder

  2022cites this paper
• Antidepressant effects of acupuncture in a murine model: regulation of neurotrophic factors

  2022cites this paper
• Therapeutic Implications of microRNAs in Depressive Disorders: A Review

  2022cites this paper
• Neuroimaging Studies of Effects of Psychotherapy in Depression

  2021cites this paper
• Magnetoencephalography Studies in Mood Disorders

  2021cites this paper
• Brain Imaging and the Mechanisms of Antidepressant Action

  2021cites this paper
• Quantitative evaluation of the cerebellum in patients with depression and healthy adults by VolBrain method

  2021cites this paper
• Brain Imaging Methods in Mood Disorders

  2021cites this paper
• The Resilient Phenotype Induced by Prophylactic Ketamine Exposure During Adolescence Is Mediated by the Ventral Tegmental Area-Nucleus Accumbens Pathway.

  2021cites this paper
• Major Depression: One Brain, One Disease, One Set of Intertwined Processes

  2021cites this paper
• Neuroimaging Brain Inflammation in Mood Disorders

  2021cites this paper
• Molecular Imaging of Dopamine and Antipsychotics in Bipolar Disorder

  2021cites this paper
• Resting-State Functional Connectivity in Unipolar Depression

  2021cites this paper
• Imaging Genetic and Epigenetic Markers in Mood Disorders

  2021cites this paper
• Neurogenic hypothesis of positive psychology in stress-induced depression: Adult hippocampal neurogenesis, neuroinflammation, and stress resilience.

  2021cites this paper
• Ventral striatal activation during reward differs between major depression with and without impaired mood reactivity.

  2021cites this paper
• Ketamine and the Future of Rapid-Acting Antidepressants.

  2021cites this paper
• PTEN in prefrontal cortex is essential in regulating depression-like behaviors in mice

  2021cites this paper
• R (-)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine.

  2021cites this paper
• Atualizações científicas sobre a deficiência de vitamina D, de ácido fólico e magnésio na depressão

  2021cites this paper
• Neuroanatomical Findings in Unipolar Depression and the Role of the Hippocampus

  2021cites this paper
• Medicinal Plants in the Treatment of Depression. II: Evidence from Clinical Trials

  2021cites this paper
• Original experimental rat model of blast-induced mild traumatic brain injury: a pilot study

  2021cites this paper
• Functional Near-Infrared Spectroscopy Studies in Mood Disorders

  2021cites this paper
• fMRI Neurofeedback as Treatment for Depression

  2021cites this paper
• Integrating Endocannabinoid Signalling In Depression

  2021cites this paper
• Functional Connectome in Bipolar Disorder

  2021cites this paper
• Electrophysiological Biomarkers for Mood Disorders

  2021cites this paper
• Magnetic Resonance Spectroscopy Investigations of Bioenergy and Mitochondrial Function in Mood Disorders

  2021cites this paper
• Imaging Glutamatergic and GABAergic Abnormalities in Mood Disorders

  2021cites this paper
• Perisynaptic astrocytes as a potential target for novel antidepressant drugs.

  2021cites this paper
• Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression

  2021cites this paper
• Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review

  2021cites this paper
• Neuroanatomical Findings in Bipolar Disorder

  2021cites this paper
• Neuroimaging Biomarkers in Pediatric Mood Disorders

  2021cites this paper
• Ketamine vs Midazolam: Mood Improvement Reduces Suicidal Ideation in Depression.

  2021cites this paper
• An Overview of Machine Learning Applications in Mood Disorders

  2021cites this paper
• Neural and genetic correlates of cognitive deficits in major depressive disorder

  2021cites this paper
• DHEA and polycystic ovarian syndrome: Meta-analysis of case-control studies

  2021cites this paper
• Melatonin attenuated the behavioral despair induced by acute neurogenic stress through blockade of N-methyl D-aspartate receptors in mice

  2021cites this paper